# A Phase IV Study of Cipro XR in Uncomplicated UTI

> **NCT00663806** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 7614 (actual)

## Conditions studied

- Urinary Tract Infections

## Interventions

- **BEHAVIORAL:** Cipro XR (Ciprofloxacin, BAYQ3939)
- **BEHAVIORAL:** Cipro XR (Ciprofloxacin, BAYQ3939)

## Key facts

- **NCT ID:** NCT00663806
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** 2003-07
- **Target enrollment:** 7614 (ACTUAL)
- **Last updated:** 2014-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00663806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00663806, "A Phase IV Study of Cipro XR in Uncomplicated UTI". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00663806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*